icone plus
Contact Abonnez-vous aux actualités
Reason for request
Modification du RCP
Modification d’AMM du 02/07/2018 : restriction de l’indication aux patients ayant une tumeur avec expression de PD-L1 ≥ 5% dans le traitement du carcinome urothélial chez les patients inéligibles au cisplatine
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
jrXtnw6gsG45EqYy
Listen
